Skip to main content

Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis

European Journal of Nutrition volume 52, pages 705–715 (2013)Cite this article

Abstract

Purpose

The relationship between habitual consumption of foods with a high glycemic index (GI) and/or a diet with a high glycemic load (GL) and risk of endometrial cancer is uncertain, and relatively few studies have investigated these associations. The objectives of this study were to examine the association between GI/GL and risk of endometrial cancer using data from an Australian population-based case–control study and systematically review all the available evidence to quantify the magnitude of the association using meta-analysis.

Methods

The case–control study included 1,290 women aged 18–79 years with newly diagnosed, histologically confirmed endometrial cancer and 1,436 population controls. Controls were selected to match the expected Australian state of residence and age distribution (in 5-year bands) of cases. For the systematic review, relevant studies were identified by searching PubMed and Embase databases through to July 2011. Random-effects models were used to calculate the summary risk estimates, overall and dose–response.

Results

In our case–control study, we observed a modest positive association between high dietary GI (OR 1.43, 95 % CI 1.11–1.83) and risk of endometrial cancer, but no association with high dietary GL (OR 1.15, 95 % CI 0.90–1.48). For the meta-analysis, we collated information from six cohort and two case–control studies, involving a total of 5,569 cases. The pooled OR for the highest versus the lowest intake category of GI was 1.15 (0.95–1.40); however, there was significant heterogeneity (p 0.004) by study design (RR 1.00 [95 % CI 0.87–1.14] for cohort studies and 1.56 [95 % CI 1.21–2.02] for case–control studies). There was no association in the dose–response meta-analysis of GI (RR per 5 unit/day increment of GI 1.00, 95 % CI 0.97–1.03). GL was positively associated with endometrial cancer. The pooled RR for the highest versus the lowest GL intake was 1.21 (95 % CI 1.09–1.33) and 1.06 (95 % CI 1.01–1.11) per 50 unit/day increment of GL in the dose–response meta-analysis.

Conclusion

The pooled results from observational studies, including our case–control results, provide evidence of a modest positive association between high GL, but not GI, and endometrial cancer risk.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531–1543

    CAS  Google Scholar 

  2. Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quiros JR, Agudo A, Sanchez MJ, Larranaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R (2007) Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120(12):2656–2664. doi:10.1002/ijc.22578

    Article  CAS  Google Scholar 

  3. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108(2):262–268. doi:10.1002/ijc.11544

    Article  CAS  Google Scholar 

  4. Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115(2):86–96. doi:10.1080/13813450902878054

    Article  CAS  Google Scholar 

  5. Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59(3 Suppl):699S–705S

    CAS  Google Scholar 

  6. Brand-Miller J, McMillan-Price J, Steinbeck K, Caterson I (2009) Dietary glycemic index: health implications. J Am Coll Nutr 28(Suppl):446S–449S

    CAS  Google Scholar 

  7. Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287(18):2414–2423

    Article  CAS  Google Scholar 

  8. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C (2003) Glycemic index and glycemic load in endometrial cancer. Int J Cancer 105(3):404–407. doi:10.1002/ijc.11089

    Article  CAS  Google Scholar 

  9. Silvera SA, Rohan TE, Jain M, Terry PD, Howe GR, Miller AB (2005) Glycaemic index, glycaemic load and risk of endometrial cancer: a prospective cohort study. Public Health Nutr 8(7):912–919

    Article  Google Scholar 

  10. Cui X, Rosner B, Willett WC, Hankinson SE (2011) Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 20(5):978–989

    Article  CAS  Google Scholar 

  11. Cust AE, Slimani N, Kaaks R, van Bakel M, Biessy C, Ferrari P, Laville M, Tjonneland A, Olsen A, Overvad K, Lajous M, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Rohrmann S, Nothlings U, Boeing H, Palli D, Sieri S, Panico S, Tumino R, Sacerdote C, Skeie G, Engeset D, Gram IT, Quiros JR, Jakszyn P, Sanchez MJ, Larranaga N, Navarro C, Ardanaz E, Wirfalt E, Berglund G, Lundin E, Hallmans G, Bueno-de-Mesquita HB, Du H, Peeters PH, Bingham S, Khaw KT, Allen NE, Key TJ, Jenab M, Riboli E (2007) Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European prospective investigation into cancer and nutrition cohort. Am J Epidemiol 166(8):912–923

    Article  Google Scholar 

  12. Folsom AR, Demissie Z, Harnack L (2003) Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa women’s health study. Nutr Cancer 46(2):119–124

    Article  Google Scholar 

  13. George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A, Hollenbeck A, Subar AF (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169(4):462–472

    Article  Google Scholar 

  14. Larsson SC, Friberg E, Wolk A (2007) Carbohydrate intake, glycemic index and glycemic load in relation to risk of endometrial cancer: a prospective study of Swedish women. Int J Cancer 120(5):1103–1107. doi:10.1002/ijc.22422

    Article  CAS  Google Scholar 

  15. Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P (2008) Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87(6):1793–1801

    CAS  Google Scholar 

  16. Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM (2008) Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer 99(3):434–441

    Article  CAS  Google Scholar 

  17. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC (2008) Glycemic index, glycemic load, and chronic disease risk–a meta-analysis of observational studies. Am J Clin Nutr 87(3):627–637

    CAS  Google Scholar 

  18. Mulholland HG, Murray LJ, Cantwell MM (2008) Glycemic index, glycemic load, and chronic disease risk. Am J Clin Nutr 88 (2):475–476; author reply 476–477

    Google Scholar 

  19. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM (2011) Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol 123(3):537–541

    Article  Google Scholar 

  20. Merritt MA, Green AC, Nagle CM, Webb PM (2008) Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 122(1):170–176

    Article  CAS  Google Scholar 

  21. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122(1):51–65

    CAS  Google Scholar 

  22. McNaughton SA, Marks GC, Gaffney P, Williams G, Green A (2005) Validation of a food-frequency questionnaire assessment of carotenoid and vitamin E intake using weighed food records and plasma biomarkers: the method of triads model. Eur J Clin Nutr 59(2):211–218

    Article  CAS  Google Scholar 

  23. Ibiebele TI, Parekh S, Mallitt KA, Hughes MC, O’Rourke PK, Webb PM (2009) Reproducibility of food and nutrient intake estimates using a semi-quantitative FFQ in Australian adults. Public Health Nutr 12(12):2359–2365

    Article  Google Scholar 

  24. Atkinson FS, Foster-Powell K, Brand-Miller JC (2008) International tables of glycemic index and glycemic load values. Diabetes Care 31(12):2281–2283

    Article  Google Scholar 

  25. Silverberg S, Kurman RJ, Nogales F et al (eds) (2003) Tumours of the uterine corpus. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IRAC Press, Lyon

    Google Scholar 

  26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  Google Scholar 

  27. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309

    CAS  Google Scholar 

  28. Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6:40–57

    Google Scholar 

  29. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  CAS  Google Scholar 

  30. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  CAS  Google Scholar 

  31. Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values. Am J Clin Nutr 76(1):5–56

    CAS  Google Scholar 

  32. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20(4):545–550

    Article  CAS  Google Scholar 

  33. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277(6):472–477

    Article  CAS  Google Scholar 

  34. Howlett J, Ashwell M (2008) Glycemic response and health: summary of a workshop. Am J Clin Nutr 87(1):212S–216S

    CAS  Google Scholar 

  35. Venn BJ, Green TJ (2007) Glycemic index and glycemic load: measurement issues and their effect on diet-disease relationships. Eur J Clin Nutr 61(Suppl 1):S122–S131

    Article  CAS  Google Scholar 

  36. Esfahani A, Wong JM, Mirrahimi A, Srichaikul K, Jenkins DJ, Kendall CW (2009) The glycemic index: physiological significance. J Am Coll Nutr 28(Suppl):439S–445S

    CAS  Google Scholar 

  37. Augustin LS, Franceschi S, Jenkins DJ, Kendall CW, La Vecchia C (2002) Glycemic index in chronic disease: a review. Eur J Clin Nutr 56(11):1049–1071. doi:10.1038/sj.ejcn.1601454

    Article  CAS  Google Scholar 

  38. Kalli KR, Conover CA (2003) The insulin-like growth factor/insulin system in epithelial ovarian cancer. Front Biosci 8:d714–d722

    Article  CAS  Google Scholar 

  39. Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14(1):98–107

    CAS  Google Scholar 

  40. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21(3):215–244

    Article  CAS  Google Scholar 

  41. Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M, Konishi I (2009) Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer 16(1):113–122

    Article  CAS  Google Scholar 

  42. Reynolds RK, Hu C, Baker VV (1998) Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Gynecol Oncol 70(2):202–209

    Article  CAS  Google Scholar 

  43. Collins A, Duthie S, Ross M (1994) Micronutrients and oxidative stress in the aetiology of cancer. Proc Nutr Soc 53(1):67–75

    Article  CAS  Google Scholar 

  44. Jeppesen J, Schaaf P, Jones C, Zhou MY, Chen YD, Reaven GM (1997) Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr 65(4):1027–1033

    CAS  Google Scholar 

  45. Marks GC, Hughes MC, van der Pols JC (2006) Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. The Journal of nutrition 136(2):459–465

    CAS  Google Scholar 

  46. Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ (2002) Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr 5 (6A):915–923. doi:10.1079/PHN2002383

    Google Scholar 

Download references

Acknowledgments

We thank all the women who participated in the study. We gratefully acknowledge the cooperation of the following institutions: NSW: John Hunter Hospital, Liverpool Hospital, Mater Misericordiae Hospital (Sydney), Mater Misericordiae Hospital (Newcastle), Newcastle Private Hospital, North Shore Private Hospital, Royal Hospital for Women, Royal Prince Alfred Hospital, Royal North Shore Hospital, Royal Prince Alfred Hospital, St George Hospital; Westmead Hospital, Westmead Private Hospital; Qld: Brisbane Private Hospital, Greenslopes Hospital, Mater Misericordiae Hospitals, Royal Brisbane and Women’s Hospital, Wesley Hospital, Queensland Cancer Registry; SA: Adelaide Pathology Partners, Burnside Hospital, Calvary Hospital, Flinders Medical Centre, Queen Elizabeth Hospital, Royal Adelaide Hospital, South Australian Cancer Registry; Tas: Launceston Hospital, North West Regional Hospitals, Royal Hobart Hospital; Vic: Freemasons Hospital, Melbourne Pathology Services, Mercy Hospital for Women, Royal Women’s Hospital, Victorian Cancer Registry; WA: King Edward Memorial Hospital, St John of God Hospitals Subiaco & Murdoch, Western Australian Cancer Registry. We also thank the authors of previously published studies who contributed information for the dose–response meta-analysis: Xiaohui Cui, Anne Cust, Aaron Folsom and Stephanie George. These analyses were supported by The Cancer Council Queensland [#496680]. The Australian National Endometrial Cancer Study was supported by the National Health and Medical Research Council (NHMRC) of Australia (#339435) and Cancer Council Tasmania (#403031 and 457636). CM Nagle, PM Webb and AB Spurdle are funded by NHMRC Fellowships.

Author information

Authors and Affiliations

  1. Gynaecological Cancers, Population Health Research Department, Queensland Institute of Medical Research, Locked Bag 2000, Royal Brisbane Hospital, Herston, Brisbane, QLD, 4029, Australia

    Christina M. Nagle, Catherine M. Olsen, Torukiri I. Ibiebele & Penelope M. Webb

  2. Molecular Cancer Epidemiology, Genetics Research Department, Queensland Institute of Medical Research, Locked Bag 2000, Royal Brisbane Hospital, Herston, Brisbane, QLD, Australia

    Amanda B. Spurdle

Authors
  1. Christina M. Nagle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine M. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Torukiri I. Ibiebele
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amanda B. Spurdle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Penelope M. Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The Australian National Endometrial Cancer Study Group

The Australian Ovarian Cancer Study Group

Corresponding author

Correspondence to Christina M. Nagle.

Additional information

The details of The Australian National Endometrial Cancer Study Group and The Australian Ovarian Cancer Study Group are given “Appendix”.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 41 kb)

Appendix

Appendix

The ANECS Group comprises: AB Spurdle, P Webb, J Young (Queensland Institute of Medical Research); Consumer representative: L McQuire; Clinical Collaborators: NSW: S Baron-Hay, D Bell, A Bonaventura, A Brand, S Braye, J Carter, F Chan, C Dalrymple, A Ferrier (deceased), G Gard, N Hacker, R Hogg, R Houghton, D Marsden, K McIlroy, G Otton, S Pather, A Proietto, G Robertson, J Scurry, R Sharma, G Wain, F Wong; Qld: J Armes, A Crandon, M Cummings, R Land, J Nicklin, L Perrin, A Obermair, B Ward; SA: M Davy, T Dodd, J Miller, M Oehler, S Paramasivum, J Pierides, F Whitehead; Tas: P Blomfield, D Challis; Vic: D Neesham, J Pyman, M Quinn, R Rome, M Weitzer; WA: B Brennan, I Hammond, Y Leung, A McCartney, C Stewart, J Thompson; Project Managers: S O’Brien, S Moore; Laboratory Manager: K Ferguson; Pathology Support: M Walsh; Admin Support: R Cicero, L Green, J Griffith, L Jackman, B Ranieri; Laboratory Assistants: M O’Brien, P Schultz; Research Nurses: B Alexander, C Baxter, H Croy, A Fitzgerald, E Herron, C Hill, M Jones, J Maidens, A Marshall, K Martin, J Mayhew, E Minehan, D Roffe, H Shirley, H Steane, A Stenlake, A Ward, S Webb, J White. Full membership of the Australian Ovarian Cancer Study Group is listed at http://www.aocstudy.org/.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nagle, C.M., Olsen, C.M., Ibiebele, T.I. et al. Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis. Eur J Nutr 52, 705–715 (2013). https://doi.org/10.1007/s00394-012-0376-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-012-0376-7

Keywords

  • Glycemic load
  • Glycemic index
  • Case–control
  • Dose–response meta-analysis
  • Endometrial cancer